The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma.
Saved in:
| Title: | The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma. |
|---|---|
| Authors: | Deng, Wei1 (AUTHOR) dw13698012072@163.com, Xie, Jin1 (AUTHOR) 18000732178@163.com, Wang, Tao2 (AUTHOR) 846936743@qq.com, Luo, Laihui1 (AUTHOR) laihui_luo@163.com, Zhu, Guoqing1 (AUTHOR) z15216021213@163.com, Xiao, Yongqiang1 (AUTHOR) johshaw0526@126.com, Tao, Jiahao1 (AUTHOR) 1396179879@qq.com, Lin, Liucong1 (AUTHOR) 2109001663@qq.com, Ge, Xian3 (AUTHOR) 1481134111@qq.com, Wen, Wu1 (AUTHOR) wenwu117906@163.com, Wang, Minglong1 (AUTHOR) 252091504@qq.com, Yu, Bin1 (AUTHOR) yubin@ncu.edu.cn, Liu, Yu1 (AUTHOR) 125106167@qq.com, Luo, Rongguang4 (AUTHOR) ndyfy02295@ncu.edu.cn, Wan, Renhua1 (AUTHOR) zww726696@sina.com, Hu, Zhigao1 (AUTHOR) 854189568@qq.com, Shan, Renfeng1 (AUTHOR) srf1978@126.com |
| Source: | BMC Cancer. 4/25/2025, Vol. 25 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-025-14185-x |
